MYC activation is a key event in the progression of the premalignant MGUS state to symptomatic MM and high MYC protein expression determines adverse outcome in MM (Chng et al, 2011; Dechow et al, 2014; Jovanovic et al, 2018). This evidence concerns the gene MYC and Miyoshi myopathy.